β-Adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 10, 2014, Pages H1497-H1503

  Ross, Amanda J ^a   Gao, Zhaohui ^a   Pollock, Jonathan P ^a   Leuenberger, Urs A ^a   Sinoway, Lawrence I ^a   Muller, Matthew D ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Coronary vessels; Exercise; Isoproterenol; Propranolol; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGED; AGING; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY EXERCISE HYPEREMIA; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; EXERCISE; FLOW RATE; HAND GRIP; HEART RATE; HUMAN; HYPEREMIA; ISOMETRIC EXERCISE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; MAXIMAL VOLUNTARY CONTRACTION; MUSCLE CONTRACTION; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; AGE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORONARY BLOOD VESSEL; CROSSOVER PROCEDURE; DRUG EFFECTS; HAND STRENGTH; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MUSCLE ISOMETRIC CONTRACTION; NORMAL HUMAN; PATHOPHYSIOLOGY; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGING; CORONARY VESSELS; CROSS-OVER STUDIES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; HAND STRENGTH; HEALTHY VOLUNTEERS; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; ISOMETRIC CONTRACTION; ISOPROTERENOL; MALE; MIDDLE AGED; PROPRANOLOL; VASODILATION;

EID: 84922392456     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00584.2014     Document Type: Article

References (59)

1. Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK, Lowell BB. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297: 843-845, 2002.
2. Barbato E. Role of adrenergic receptors in human coronary vasomotion. Heart 95: 603-608, 2009.
3. Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, De Luca G, Iaccarino G, De Bruyne B, Chiariello M, Wijns W. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation 111: 288-294, 2005.
4. Bell C, Day DS, Jones PP, Christou DD, Petitt DS, Osterberg K, Melby CL, Seals DR. High energy flux mediates the tonically augmented beta-adrenergic support of resting metabolic rate in habitually exercising older adults. J Clin Endocrinol Metab 89: 3573-3578, 2004.
5. Bell C, Seals DR, Monroe MB, Day DS, Shapiro LF, Johnson DG, Jones PP. Tonic sympathetic support of metabolic rate is attenuated with age, sedentary lifestyle, and female sex in healthy adults. J Clin Endocrinol Metab 86: 4440-4444, 2001.
6. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14: 377-381, 1982.
7. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd, Panza JA. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension 30: 918-921, 1997.
8. Casey DP, Curry TB, Joyner MJ, Charkoudian N, Hart EC. Acute beta-adrenergic blockade increases aortic wave reflection in young men and women: differing mechanisms between sexes. Hypertension 59: 145- 150, 2012.
9. DeSouza CA, Clevenger CM, Greiner JJ, Smith DT, Hoetzer GL, Shapiro LF, Stauffer BL. Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J Physiol 542: 255-262, 2002.
10. DiCarlo SE, Blair RW, Bishop VS, Stone HL. Role of beta 2-adrenergic receptors on coronary resistance during exercise. J Appl Physiol 64: 2287-2293, 1988.
11. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 88: 1009-1086, 2008.
12. Duncker DJ, Stubenitsky R, Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feedforward beta-adrenergic control. Circ Res 82: 1312-1322, 1998.
13. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88: 77-81, 1993.
14. Fitzgerald D, Doyle V, Kelly JG, O'Malley K. Cardiac sensitivity to isoprenaline, lymphocyte beta-adrenoceptors and age. Clin Sci (Lond) 66: 697-699, 1984.
15. Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 19: 653-663, 1970.
16. Gaal PG, Kattus AA, Kolin A, Ross G. Effects of adrenaline and noradrenaline on coronary blood flow before and after beta-adrenergic blockade. Br J Pharmacol Chemother 26: 713-722, 1966.
17. Gao F, de Beer VJ, Hoekstra M, Xiao C, Duncker DJ, Merkus D. Both β1- and β2-adrenoceptors contribute to feedforward coronary resistance vessel dilation during exercise. Am J Physiol Heart Circ Physiol 298: H921-H929, 2010.
18. Gao Z, Drew RC, Momen A, Ndukwu I, Muller MD, Mast J, Blaha C, Leuenberger UA, Sinoway LI. Left ventricular torsion based on 2D speckle tracking echocardiography (STE) is preload insensitive. FASEB J 26: 864.15, 2012.
19. Gao Z, Muller MD, Sinoway LI, Leuenberger UA. Intravenous phentolamine abolishes coronary vasoconstriction in response to mild central hypovolemia. J Appl Physiol 116: 216-221, 2014.
20. Gao Z, Novick M, Muller MD, Williams RJ, Spilk S, Leuenberger UA, Sinoway LI. Exercise and diet-induced weight loss attenuates oxidative stress related-coronary vasoconstriction in obese adolescents. Eur J Appl Physiol 113: 519-528, 2013.
21. Gao Z, Spilk S, Momen A, Muller MD, Leuenberger UA, Sinoway LI. Vitamin C prevents hyperoxia-mediated coronary vasoconstriction and impairment of myocardial function in healthy subjects. Eur J Appl Physiol 112: 483-492, 2012.
22. Gao Z, Wilson TE, Drew RC, Ettinger J, Monahan KD. Altered coronary vascular control during cold stress in healthy older adults. Am J Physiol Heart Circ Physiol 302: H312-H318, 2012.
23. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129: e28-e292, 2014.
24. Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The ratepressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 57: 549-556, 1978.
25. Gorman MW, Tune JD, Richmond KN, Feigl EO. Quantitative analysis of feedforward sympathetic coronary vasodilation in exercising dogs. J Appl Physiol 89: 1903-1911, 2000.
26. Gwirtz PA, Stone HL. Coronary blood flow changes following activation of adrenergic receptors in the conscious dog. Am J Physiol Heart Circ Physiol 243: H13-H19, 1982.
27. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106: 653-658, 2002.
28. Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach J, Joyner MJ. Sex and ageing differences in resting arterial pressure regulation: the role of the beta-adrenergic receptors. J Physiol 589: 5285-5297, 2011.
29. Harvey RE, Barnes JN, Charkoudian N, Curry TB, Eisenach JH, Hart EC, Joyner MJ. Forearm vasodilator responses to a beta-adrenergic receptor agonist in premenopausal and postmenopausal women. Physiol Rep 2: e12032, 2014.
30. Hays AG, Hirsch GA, Kelle S, Gerstenblith G, Weiss RG, Stuber M. Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol 56: 1657-1665, 2010.
31. Hodgson JM, Cohen MD, Szentpetery S, Thames MD. Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation 79: 797-809, 1989.
32. Horwitz LD, Curry GC, Parkey RW, Bonte FJ. Effect of isoproterenol on coronary blood flow in primary myocardial disease. Circulation 50: 560-564, 1974.
33. Hunt BE, Davy KP, Jones PP, DeSouza CA, Van Pelt RE, Tanaka H, Seals DR. Role of central circulatory factors in the fat-free mass-maximal aerobic capacity relation across age. Am J Physiol Heart Circ Physiol 275: H1178-H1182, 1998.
34. Johnsson G, Svedmyr N, Thiringer G. Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. Eur J Clin Pharmacol 8: 175-180, 1975.
35. Klein C, Hiatt WR, Gerber JG, Nies AS. Age does not alter human vascular and nonvascular beta 2-adrenergic responses to isoproterenol. Clin Pharmacol Ther 44: 573-578, 1988.
36. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36: 1233-1238, 2000.
37. Lakatta EG. Changes in cardiovascular function with aging. Eur Heart J 11, Suppl C: 22-29, 1990.
38. Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 57: 461-469, 1985.
39. Miyashiro JK, Feigl EO. Feedforward control of coronary blood flow via coronary beta-receptor stimulation. Circ Res 73: 252-263, 1993.
40. Momen A, Mascarenhas V, Gahremanpour A, Gao Z, Moradkhan R, Kunselman A, Boehmer J, Sinoway LI, Leuenberger UA. Coronary blood flow responses to physiological stress in humans. Am J Physiol Heart Circ Physiol 296: H854-H861, 2009.
41. Monahan KD, Feehan RP, Sinoway LI, Gao Z. Contribution of sympathetic activation to coronary vasodilatation during the cold pressor test in healthy men: Effect of ageing. J Physiol 591: 2937-2947, 2013.
42. Monroe MB, Seals DR, Shapiro LF, Bell C, Johnson D, Parker Jones P. Direct evidence for tonic sympathetic support of resting metabolic rate in healthy adult humans. Am J Physiol Endocrinol Metab 280: E740- E744, 2001.
43. Muller MD, Gao Z, Mast JL, Blaha CA, Drew RC, Leuenberger UA, Sinoway LI. Aging attenuates the coronary blood flow response to cold air breathing and isometric handgrip in healthy humans. Am J Physiol Heart Circ Physiol 302: H1737-H1746, 2012.
44. Muller MD, Gao Z, McQuillan PM, Leuenberger UA, Sinoway LI. Coronary responses to cold air inhalation following afferent and efferent blockade. Am J Physiol Heart Circ Physiol 307: H228-H235, 2014.
45. Muller MD, Gao Z, Patel HM, Heffernan MJ, Leuenberger UA, Sinoway LI. β-Adrenergic blockade enhances coronary vasoconstrictor response to forehead cooling. Am J Physiol Heart Circ Physiol 306: H910-H917, 2014.
46. Pan HY, Hoffman BB, Pershe RA, Blaschke TF. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther 239: 802-807, 1986.
47. Puri R, Liew GY, Nicholls SJ, Nelson AJ, Leong DP, Carbone A, Copus B, Wong DT, Beltrame JF, Worthley SG, Worthley MI. Coronary beta2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. Eur Heart J 33: 495-504, 2012.
48. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO 3rd. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 92: 320-326, 1995.
49. Robinson MM, Bell C, Peelor FF 3rd, Miller BF. β-Adrenergic receptor blockade blunts postexercise skeletal muscle mitochondrial protein synthesis rates in humans. Am J Physiol Regul Integr Comp Physiol 301: R327-R334, 2011.
50. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: 1899-1906, 2000.
51. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond) 120: 357-375, 2011.
52. Stratton JR, Cerqueira MD, Schwartz RS, Levy WC, Veith RC, Kahn SE, Abrass IB. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 86: 504-512, 1992.
53. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38: 274-279, 2001.
54. Trivella MG, Broten TP, Feigl EO. β-Receptor subtypes in the canine coronary circulation. Am J Physiol Heart Circ Physiol 259: H1575- H1585, 1990.
55. Turner MJ, Mier CM, Spina RJ, Schechtman KB, Ehsani AA. Effects of age and gender on the cardiovascular responses to isoproterenol. J Gerontol A Biol Sci Med Sci 54: B393-B400; discussion B401-B403, 1999.
56. van Brummelen P, Buhler FR, Kiowski W, Amann FW. Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci (Lond) 60: 571-577, 1981.
57. Welle S, Schwartz RG, Statt M. Reduced metabolic rate during betaadrenergic blockade in humans. Metabolism 40: 619-622, 1991.
58. White M, Leenen FH. Aging and cardiovascular responsiveness to beta-agonist in humans: role of changes in beta-receptor responses versus baroreflex activity. Clin Pharmacol Ther 56: 543-553, 1994.
59. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Jr., Ganz P, Selwyn AP. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 325: 1551-1556, 1991.